Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRPL53 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | MPP5 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | PABPC4L | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | NUAK2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | POU1F1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | NPR1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | SMIM13 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | AC138969.4 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | NXPE4 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | GDF15 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |